Phibro Animal Health PE Ratio 2012-2025 | PAHC

Current and historical p/e ratio for Phibro Animal Health (PAHC) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Phibro Animal Health PE ratio as of July 18, 2025 is 15.40.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Phibro Animal Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-18 29.41 37.71
2025-03-31 21.25 $0.78 27.25
2024-12-31 20.79 $0.48 43.32
2024-09-30 22.18 $0.43 51.59
2024-06-30 16.42 $0.06 273.67
2024-03-31 12.57 $0.32 39.29
2023-12-31 11.16 $0.36 31.00
2023-09-30 12.17 $0.51 23.85
2023-06-30 12.93 $0.81 15.97
2023-03-31 14.33 $0.71 20.19
2022-12-31 12.45 $0.90 13.84
2022-09-30 12.22 $1.15 10.62
2022-06-30 17.44 $1.21 14.42
2022-03-31 18.08 $1.45 12.47
2021-12-31 18.40 $1.31 14.04
2021-09-30 19.30 $1.20 16.09
2021-06-30 25.75 $1.34 19.22
2021-03-31 21.66 $1.06 20.44
2020-12-31 17.15 $1.09 15.73
2020-09-30 15.27 $1.06 14.40
2020-06-30 22.92 $0.82 27.95
2020-03-31 20.99 $0.90 23.32
2019-12-31 21.46 $0.94 22.83
2019-09-30 18.34 $1.01 18.16
2019-06-30 27.16 $1.35 20.12
2019-03-31 28.10 $1.68 16.73
2018-12-31 27.27 $1.80 15.15
2018-09-30 36.25 $1.61 22.51
2018-06-30 38.83 $1.60 24.27
2018-03-31 33.40 $1.43 23.36
2017-12-31 28.12 $1.53 18.38
2017-09-30 31.00 $1.70 18.24
2017-06-30 30.91 $1.62 19.08
2017-03-31 23.38 $1.62 14.43
2016-12-31 24.29 $1.49 16.30
2016-09-30 22.45 $1.90 11.82
2016-06-30 15.35 $2.06 7.45
2016-03-31 22.13 $1.94 11.41
2015-12-31 24.57 $1.97 12.47
2015-09-30 25.72 $1.61 15.98
2015-06-30 31.58 $1.66 19.02
2015-03-31 28.63 $0.93 30.79
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.205B $1.018B
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Currently, Phibro focuses on regions where the majority of livestock production is consolidated in large commercial farms such as the U.S., Brazil, China, Russia, Mexico, Australia, Turkey, Israel, Canada and Europe.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $209.668B 24.59
Boston Scientific (BSX) United States $154.824B 38.76
Stryker (SYK) United States $148.439B 31.04
EssilorLuxottica (ESLOY) France $131.494B 0.00
Medtronic (MDT) Ireland $114.826B 16.28
Lonza Group Ag (LZAGY) Switzerland $49.743B 0.00
Haleon (HLN) United Kingdom $43.081B 24.59
ResMed (RMD) United States $37.598B 28.24
GE HealthCare Technologies (GEHC) United States $34.909B 16.57
Agilent Technologies (A) United States $33.054B 21.55
Terumo (TRUMY) Japan $24.345B 31.62
Koninklijke Philips (PHG) Netherlands $23.697B 16.63
Insulet (PODD) United States $19.948B 78.30
Zimmer Biomet Holdings (ZBH) United States $18.776B 12.06
Baxter (BAX) United States $14.312B 10.69
Smith & Nephew SNATS (SNN) United Kingdom $13.087B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.794B 23.64
Lantheus Holdings (LNTH) United States $5.092B 12.85
Perrigo (PRGO) Ireland $3.733B 9.46
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.529B 16.07
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.347B 27.82
ICU Medical (ICUI) United States $3.070B 22.64
LeMaitre Vascular (LMAT) United States $1.855B 41.47
QuidelOrtho (QDEL) United States $1.804B 12.41
AtriCure (ATRC) United States $1.473B 0.00
Acuren (TIC) United States $1.444B 0.00
AdaptHealth (AHCO) United States $1.242B 12.60
Green Thumb Industries (GTBIF) United States $1.207B 27.14
Neogen (NEOG) United States $1.055B 13.50
BioLife Solutions (BLFS) United States $1.025B 0.00
InMode (INMD) Israel $0.891B 8.98
Kestra Medical Technologies (KMTS) United States $0.845B 0.00
Curaleaf Holdings (CURLF) Canada $0.674B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
Owens & Minor (OMI) United States $0.617B 5.12
Tilray Brands (TLRY) Canada $0.615B 0.00
Evolus (EOLS) United States $0.602B 0.00
CeriBell (CBLL) United States $0.565B 0.00
Valneva SE (VALN) France $0.553B 0.00
Surmodics (SRDX) United States $0.438B 0.00
SNDL (SNDL) Canada $0.410B 0.00
Capricor Therapeutics (CAPR) United States $0.327B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Sanuwave Health (SNWV) United States $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.275B 0.00
Cresco Labs (CRLBF) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.262B 0.00
Aurora Cannabis (ACB) Canada $0.256B 75.83
OraSure Technologies (OSUR) United States $0.245B 0.00
Sanara MedTech (SMTI) United States $0.244B 0.00
ZimVie (ZIMV) United States $0.241B 10.96
Biote (BTMD) United States $0.228B 6.42
Brainsway (BWAY) Israel $0.219B 58.05
Verano Holdings (VRNOF) United States $0.204B 0.00
Canopy Growth (CGC) Canada $0.204B 0.00
Omeros (OMER) United States $0.204B 0.00
High Tide (HITI) Canada $0.203B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.82
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Exagen (XGN) United States $0.153B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.125B 15.33
TerrAscend (TSNDF) Canada $0.107B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
Fonar (FONR) United States $0.099B 12.74
MacroGenics (MGNX) United States $0.097B 0.00
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Safety Shot (SHOT) United States $0.052B 0.00
United-Guardian (UG) United States $0.042B 14.54
Nephros (NEPH) United States $0.038B 51.14
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00